| 000 | 01937 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250517051705.0 | ||
| 264 | 0 | _c20170620 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1468-3288 | ||
| 024 | 7 |
_a10.1136/gutjnl-2014-308883 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLoyer, Xavier | |
| 245 | 0 | 0 |
_aLiver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression. _h[electronic resource] |
| 260 |
_bGut _c11 2016 |
||
| 300 |
_a1882-1894 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDiet, High-Fat |
| 650 | 0 | 4 |
_aGene Expression Profiling _xmethods |
| 650 | 0 | 4 |
_aHepatocytes _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLipid Metabolism |
| 650 | 0 | 4 |
_aLipoproteins, LDL _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMicroRNAs _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNon-alcoholic Fatty Liver Disease _xmetabolism |
| 650 | 0 | 4 |
_aOligonucleotides _xmetabolism |
| 650 | 0 | 4 |
_aPPAR alpha _xantagonists & inhibitors |
| 700 | 1 | _aParadis, Valérie | |
| 700 | 1 | _aHénique, Carole | |
| 700 | 1 | _aVion, Anne-Clémence | |
| 700 | 1 | _aColnot, Nathalie | |
| 700 | 1 | _aGuerin, Coralie L | |
| 700 | 1 | _aDevue, Cécile | |
| 700 | 1 | _aOn, Sissi | |
| 700 | 1 | _aScetbun, Jérémy | |
| 700 | 1 | _aRomain, Mélissa | |
| 700 | 1 | _aPaul, Jean-Louis | |
| 700 | 1 | _aRothenberg, Marc E | |
| 700 | 1 | _aMarcellin, Patrick | |
| 700 | 1 | _aDurand, François | |
| 700 | 1 | _aBedossa, Pierre | |
| 700 | 1 | _aPrip-Buus, Carina | |
| 700 | 1 | _aBaugé, Eric | |
| 700 | 1 | _aStaels, Bart | |
| 700 | 1 | _aBoulanger, Chantal M | |
| 700 | 1 | _aTedgui, Alain | |
| 700 | 1 | _aRautou, Pierre-Emmanuel | |
| 773 | 0 |
_tGut _gvol. 65 _gno. 11 _gp. 1882-1894 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/gutjnl-2014-308883 _zAvailable from publisher's website |
| 999 |
_c25230898 _d25230898 |
||